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Abstract 
Introduction and aims: For a scaffold material to be considered effective and 
efficient for tissue engineering it must be biocompatible as well as bioinductive. Silk 
fiber is a natural biocompatible material suitable for scaffold fabrication; however, 
silk is tissue-conductive and lacks tissue-inductive properties. One proposed method 
to make the scaffold tissue-inductive is to introduce plasmids or viruses encoding a 
specific growth factor into the scaffold. In this study, we constructed adenoviruses 
encoding bone morphogenetic protein-7 (BMP-7) and incorporated these into silk 
scaffolds. The osteo-inductive and new bone formation properties of these constructs 
were assessed in vivo in a critical-sized skull defect animal model.   
Materials and methods: Silk fibroin scaffolds containing adenovirus particles coding 
BMP-7 were prepared. The release of the adenovirus particles from the scaffolds was 
quantified by tissue-culture infective dose (TCID50) and the bioactivity of the 
released viruses was evaluated on human bone marrow mesenchymal stromal cells 
(BMSCs). To demonstrate the in vivo bone forming ability of the virus-carrying silk 
fibroin scaffold, the scaffold constructs were implanted into calvarial defects in SCID 
mice.  
Results: In vitro studies demonstrated that the virus-carrying silk fibroin scaffold 
released virus particles over a 3 week period while preserving their bioactivity. In vivo 
test of the scaffold constructs in critical-sized skull defect areas revealed that silk 
scaffolds were capable of delivering the adenovirus encoding BMP-7, resulting 
significantly enhanced new bone formation. 
Conclusions: Silk scaffolds carrying BMP-7 encoding adenoviruses can effectively 
transfect cells and enhance both in vitro and in vivo osteogenesis. The findings of this 
study indicate silk fibroin is a promising biomaterial for gene delivery to repair 
critical-sized bone defects.  
 
Introduction 
Innate bioactivity is one of the most important aspects when considering scaffold 
materials suitable for tissue engineering designs. Other properties such as 
biocompatibility, biodegradability, mechanical strength and induction of tissue 
regeneration, will determine the final potential for clinic application of the materials. 
A variety of bioactive materials including polymers, collagens, gels, ceramics and 
metals have been used as scaffolds to carry cells, growth factors, or both, to repair a 
variety of tissue defects (1-7). Some such materials have deleterious properties for 
their intended application. For example, some materials require toxic solvents when 
molded into a scaffold and take long time to degrade in vivo (8). Polymers such as 
collagens or gels are too soft or fragile to withstand external stresses, whereas 
ceramics are useful for treating hard tissue defects, but tend to be brittle and fracture 
easily. With metallic scaffolds biocompatibility and biodegradability are the major 
concerns, leaving this type of materials unsuitable for many tissue engineering areas. 
Ideally, scaffolds for effective and efficient tissue engineering should be 
biocompatible as well as bioinductive, which means the scaffold needs to actively 
induce the differentiation and regeneration of surrounding cells or tissue, from either 
the host or donor sources, in the tissue defect areas. And finally, the scaffold material 
must be non-cytotoxic when applied in vivo. 
Silk fibroin is a natural, biocompatible material suitable for tissue engineering (9, 10) 
and has several advantages compared with other biomaterials. The material is 
naturally water soluble, facilitating easy fabrication; toxic solvents are therefore not 
required. Silk fibers have greater mechanical strength than collagens or gels and 
gradually degrade in vivo. In spite of the many advantages of silk fibers as a scaffold 
material, they are tissue-conductive but not inductive, and this represents its major 
disadvantage. There are a number of methods for introducing growth factors or 
bioactive proteins into the tissue defect areas; For example: (i) by direct addition of 
growth factor into scaffolds (11); (ii) through specific protein-expressing cells 
delivered by scaffolds; or (iii) through plasmids or viruses encoding a specific protein 
incorporated within scaffolds.  
Bone morphogenetic protein-7 (BMP-7) is a growth factor with a proven ability to 
induce new bone formation both in vitro and in vivo (7, 12-14). The method of 
adenovirus transfection can produce stable and relatively long-term expression of the 
protein of interest. Adenovirus is one of the most commonly used viruses to transfect 
cells and has been proven biosafe when used in vivo (15) In this study, BMP-7 
encoding adenoviruses were constructed and impregnated within the silk scaffolds. 
The osteo-inductivity and new bone formation by this bio-activated silk scaffold were 
tested in a critical-sized skull defect in mice model. This is the first ever report of 
gene delivery of BMP-7 using silk fibroin scaffold in bone regeneration. 
  2.1. Materials  
CellTiter 96 AQueous One solution reagent (MTS) was purchased from Promega 
(Promega, Alexandria NSW, Australia). Dulbecco’s Modified Eagle’s Medium 
(DMEM) and fetal bovine serum (FBS) were from Gibco (Gibco BRL/Life 
Technologies, Victoria, Australia). All other reagents were analytical grade.  
Silk fibroin protein was extracted from mulberry silk cocoons following standard 
extraction procedures (16). Cocoons were cut into 1cm2 pieces, then boiled in an 
aqueous solution of 20 mM Na2CO3 for 30 min (~ 10% w/v of silk cocoons and 
Na2CO3) to remove all traces of sericin to completely degum the samples. The 
cocoon pieces were then washed thoroughly in distilled water and dried for 1 h at 
50°C. Degummed shell pieces were dissolved in 9.3 M lithium bromide for 4 h at 
60°C and then centrifuged to remove the insoluble material. The supernatant was 
dialyzed extensively for 3 days against deionized water with frequent changes. The 
protein concentration was then measured using bicinchoninic acid (BCA) protein 
assay (Progen Industries Ltd, Australia) (17). 
Recombinant adenoviruses were created using the Ad-Easy system (Stratagene, La 
Jolla, CA, USA). Production of the recombinant viruses (Ad-BMP-7) were performed 
as described in detail by our previous study (7). Adenovirus purification and 
concentration were done using the method of Ugai et al (18), and viral titers were 
estimated by the tissue-culture infective dose (TCID50), which obtained 1.8 ×1011 
PFU/ml.  
 
2.2. Fabrication of porous silk scaffolds containing adenoviruses 
Porous 3D silk fibroin scaffolds containing adenovirus were fabricated according to 
the following procedure: 2 ml of viscous silk solution (7% w/v) was gently mixed 
with 2 ml adenovirus solution resulting the final silk concentration of 3.5% w/v, then 
this mixture was transferred into plastic dishes at 4ºC for half an hour, then placed in a 
freezer at -35ºC for 12 h to solidify the solvent and induce solid–liquid phase 
separation. The solidified mixture was maintained at -80ºC for 2 h and was transferred 
into a freeze-drying vessel (OHRIST BETA 1-15, Germany) for 48 h until dry, after 
which the dried samples were treated with 90% (v/v) ethanol for half an hour to 
induce crystallization and sterilization. The resulting silk scaffolds were washed 
repeatedly with sterile phosphate buffered saline (PBS) in a biosafety hood to remove 
any residual alcohol before cell culture. Scaffolds of silk solutions (3.5% w/v) without 
adenovirus were prepared as negative control samples.  
 
2.3 Scanning electron microscopy (SEM) examination.  
The porous scaffold structures containing adenovirus were studied by scanning 
electron microscopy (SEM, QUANTA 200 Environmental SEM). Human bone 
marrow stem cells (BMSCs) were cultured for 1 and 7 days on the scaffolds, then 
fixed with 2.5% glutaraldehyde in 0.1 mol L-1 sodium cacodylate buffer ( pH 7.3) for 
3 h at room temperature, then washed with PBS, and dehydrated in a graded ethanol 
series. Samples were then critical point dried, coated with gold, and observed under 
SEM.  
 
2.4. Release of viruses from scaffolds 
Scaffolds (1 mg) were placed in 1.5 ml cryogenic vials containing 1 ml of sterile 
PBS (pH 7.4), and incubated at 37ºC on a shaker for 21 days. At days 2, 4, 7, 14, and 
21, all media was removed and replaced by the fresh PBS. The number of released 
viruses was quantified by plaque assay. Quantification of infectivity of the media 
removed from the different time points was performed by the end-point dilution 
method (TCID50) using 96-well plates and HEK293 cells. 
 
2.5. Transfection efficiency on BMSCs   
Human BMSCs were isolated and cultured as previously described (19, 20). One 
milligram of adenovirus containing scaffolds were incubated at 37ºC in complete 
growth media (DMEM plus serum) for 21 days. The medium was removed at 2, 4, 7, 
14, and 21 days to evaluate the transfection efficiency on BMSCs. Transfection 
efficiencies were evaluated 48 hours after cell infection by viruses and fluorescence 
emission of cells infected with adenovirus constructs containing green fluorescence 
protein (Ad-GFP) using a fluorescence microscope (Leica® DM IRB inverted 
microscope).  
 
2.6. Enzyme-linked immunosorbent assay (ELISA) 
The BMP-7 secreted by the infected BMSCs into culture medium was determined 
using a commercial BMP-7  ELISA kit (R&D Systems Inc, Minneapolis) according 
to the manufacturer's instructions at day 2, 4，7，14 and 21. Briefly, the culture 
medium was replaced with serum-free medium 24 h before each assay at different 
time point, and then the media was collected for the evaluation.  
 
2.7. In vivo studies 
A calvarial defect model in SCID mice was used to determine the bone forming 
ability of the silk fibroin scaffolds impregnate with BMP-7 adenovirus. Samples 
were divided into the following four groups: (1) control group where the defect was 
left untreated; (2) scaffold+adenovirus group where the defect was filled with 
scaffolds impregnated with virus alone; (3) Scaffold+BMP-7 adenovirus 
(Ad-BMP-7) group where the defect filled with scaffolds impregnated with BMP-7 
adenovirus; and (4) Scaffold+ Ad-BMP-7 +BMSCs group where the defect filled 
with scaffolds carrying BMP-7 adenovirus and seeded with BMSCs. Each group 
contained five animal samples. In Group 4 scaffolds containing adenovirus were cut 
into 3×3×1 mm pieces and transferred into 24-well plastic culture plates. A total of 
1x105 BMSCs were seeded onto each scaffold. After 1 day incubation, the cell and 
scaffold complex was implanted into the bone defect.  
Each surgical procedure was performed under aseptic conditions under general 
anesthesia in accordance with the Animal Research and Care Committee of the 
Herston Medical Research Centre. A linear incision (1 cm long) was made in the left 
skull to reveal the bone surface. The periosteum was dissected from the bone surface 
and a full-thickness calvarial bone defect, 3 mm in diameter, was created with a 
trephine bur in a slow-speed dental drill. To prevent overheating, 0.9% physiological 
saline was dropped onto the contact point between the bur and bone. Care was taken 
to avoid injury to the dura in all animals. The implant was trimmed to fit the defect 
and placed precisely into the defects, and soft tissue above the defect was closed 
with skin staples.  
 
2.8. Micro-computed tomography (μCT) and histology 
Animals were euthanized 4 weeks after surgery and defect areas were dissected. 
After fixed in 4% paraformaldehyde for 12 hr at room temperature, tissues were used 
for μCT analysis. μCT analysis was used to quantitatively measure the amount of 
bone formation within the defect. All samples were scanned after implant retrieval 
with μCT40 imaging system (Scanco Medical, Bassersdorf, Switzerland). The 
following scan parameters were employed: 20 mm field of view, 55 kVp x-ray 
energy setting, 1024 reconstruction matrix, slice thickness 0.02 mm, and a 250 
millisecond integration time. Mineralized tissue was segmented from 
non-mineralized tissue using a global thresholding procedure with a value 
approximating 1.20 g/cm3 (150 on μCT) (25% lower than 1.6 g/cm3 which is the 
mineral density of healthy human compact bone. Bone volume per defect (BV; mm3) 
was recorded as the measure of defect bone regeneration. 
After the MicroCT scanning, tissue samples were immersed in 10% EDTA with 
changes twice a week for 2 to 3 weeks until complete decalcification, then embedded 
in paraffin. Serial sections of 5 µm were cut and mounted on polylysine-coated 
slides. All sections were stained with hematoxylin and eosin for general assessment 
of the tissue and wound healing. 
 
2.9. Immunohistochemistry 
Monoclonal antibody against human type I collagen (COL1) and monoclonal 
anti-human alkaline phosphatase (ALP) antibody were from Sigma-Aldrich (St. 
Louis, MO). Goat anti-human Osteopontin (OPN) polyclonal antibody was from 
Biomedical Technologies (Stoughton, MA). Specimens were examined with light 
microscope.  
Endogenous peroxidase activity was quenched by incubating the tissue sections 
with 3% H2O2 for 20 min before staining with immunoperoxidase. All sections were 
blocked by 0.1% bovine serum albumin (BSA) with 10% swine serum. Sections 
were then incubated with the optimal dilution of primary antibody for ALP (1:200), 
COL1 (1:100), OPN (1:2000), overnight at 4°C. Sections were then incubated with a 
biotinylated swine anti-mouse, anti-goat antibody (Multilink; DakoCytomation, 
Carpinteria, CA) for 15 min, and then incubated with horseradish 
peroxidase-conjugated avidin–biotin complex (ABC) for 15 min. Antibody 
complexes were visualized after the addition of a buffered diaminobenzidine (DAB) 
substrate for 4 min. The reaction was stopped by immersion and rinsing of sections 
in PBS. Sections were then lightly counterstained with Mayer’s hematoxylin and 
Scott’s blue for 40 s each, in between 3 min rinses with running water. Subsequently, 
sections were dehydrated with ascending concentrations of ethanol solutions, cleared 
with xylene, and mounted with a coverslip and DePeX mounting medium (BDH 
Laboratory Supplies, Poole, UK). 
Controls for the performance of the immunostaining procedures included 
conditions under which the primary antibody or the secondary (anti-mouse IgG) 
antibody was omitted; in addition, an irrelevant IgG, which should not have been 
present in the test sections, was used as a control. To ensure that the procedure itself 
was not resulting in nonspecific staining, various safeguards were used. These 
included elimination of the primary antibody incubation step, in the presence of all 
other steps; and normal primary antibody incubation followed by elimination of 
either the secondary antibody or one of the other subsequent detection steps. 
 
 
 
Results 
3.1 Scaffold morphology 
High porosity silk scaffolds were prepared by solid–liquid phase separation. Figure 1 
shows SEM images of freeze-dried scaffolds which had highly interconnected and 
porous structures (Fig. 1A&B). The general size of pores observed was 150±46 μm, 
which was appropriate for cell migration and expansion. Figure 1C showed that the 
image of one day after cell seeding, cells appeared to be flat and were seen evenly 
distributed inside the scaffolds, although cell numbers were low. After one week 
incubation, the cell number (Fig. 1D) increased considerably and almost covered the 
material surface compared to the cell number in day one (Fig. 1C). No difference was 
observed on cell morphology and cell numbers (data not shown) between scaffold 
containing virus and scaffold alone. 
 
 
3.2. Adenovirus release in vitro 
The TCID50 method was used to estimate the release profile of the viruses 
impregnated in the scaffolds stored at 37ºC on a shaker for 21 days. When incubating 
the scaffolds carrying adenovirus in PBS buffer, the amount of viruses released from 
the scaffolds decreased over time. The profile of adenovirus release from the silk 
fibroin scaffolds showed an initial burst release, and then continued with a sustained 
release until day 21 (Fig. 2).  
 
 
3.3. Infection of BMSCs  
In order to determine if the integrity and bioactivity of loaded adenovirus was 
preserved in the silk scaffold preparation, we investigated the infectivity of 
adenovirus released from scaffolds on BMSCs in complete growth media (DMEM 
plus 10% serum). The number of GFP expressing cells gave a measure of transfection 
efficiencies of cells and reflected the amount of infective adenoviral particles, and this 
was seen in the scaffold release media collected from days 2, 4, and 7 (Fig. 3A&B). 
At day 14 there were still some infected BMSCs, but the infected cell numbers and 
GFP intensity were significantly less than the earlier time points (Fig. 3A&B).  
The BMP-7 protein secreted by the infected BMSCs was tested using a BMP-7 
ELISA kit. BMP-7 concentration in the media collected at different time point 
increased timely and peaked on day 7, then slightly decreased thereafter till day 
21(Fig.3C). These results suggested that the Ad-BMP-7 impregnated in the silk 
scaffolds were well protected from serum inactivation in contrast to the naked 
adenovirus which was completely inactivated after incubation in culture media for 24 
h (data not shown).   
 
 
3.4. μCT analysis of bone formation 
Quantitative analysis of in vivo mineralization was performed by μCT scanning. 
This analysis showed that orthotopic bone volumes had increased significantly in the 
in the defect areas treated with silk scaffold carrying BMP-7 gene (Fig. 4C) and silk 
scaffold carrying BMP-7 gene with BMSCs (Fig. 4D) compared to empty control 
(Fig. 4A) and defect filled with silk scaffold containing adenovirus alone (Fig. 4B). 
There were some minor mineral islands seen in defect areas in the empty control 
group. There was no complete mineralized tissue bridging in any of the skull defects 
after 4 weeks of implantation, but there was more mineralized tissue in the defects 
filled with silk scaffold compared with empty control (Fig. 4). μCT measurements did 
not yield statistically significant differences between scaffolds carrying the BMP-7 
gene and scaffolds carrying BMP-7 gene plus BMSCs (Fig. 4).  
   
 
3.5. Histology 
The histological analyses of bone formation supported the data obtained by μCT. 
Unfilled calvarial defects were covered with a thin fibrous connective tissue sheet 
without any new bone formation (Fig. 5 A). Bone defects filled with silk scaffold 
containing virus alone showed increased amounts of cells and fibrous tissue within the 
defects, however, no obvious new bone was visible (Fig. 5 B). The defects filled with 
silk scaffolds impregnated with Ad-BMP-7 with (Fig. 5D) or without BMSCs (Fig. 
5C) resulted in new bone formation in the defect areas. The newly formed bone had a 
woven and trabecular appearance with osteoblasts and osteoid depositions along the 
new bone surface (Fig. 5C-F). The appearance of new bone formed inside the pores of 
the Ad-BMP-7 loaded scaffolds was similar to bone formed in the scaffolds combined 
Ad-BMP-7 and seeded BMSCs (Fig.5E&F). Blood vessels containing erythrocytes 
could also be seen surrounding the newly formed bone tissues (Fig.5E&F). The newly 
formed bone islands inside Ad-BMP-7 loaded silk scaffold with or without BMSCs 
had the bone matrix with strong positive expression of bone matrix proteins such as 
type I collagen (Fig. 6 A&D) and osteopontin (Fig. 6 C&F). Active osteoblasts, which 
showed strong ALP expression, were also detected lining around this newly formed 
bone matrix in the defects filled with Ad-BMP-7 loaded silk scaffolds with or without 
BMSCs (Fig. 6 B&E).  
 
 
 
Discussion 
The loading of scaffolds with growth factors to enhance tissue regeneration has 
already been studied and reported in tissue engineering literature (21, 22). One of the 
major challenges in this respect concerns the controllable in vivo release of bioactive 
growth factors. Scaffolds impregnated with plasmids or viruses encoding growth 
factors could produce more stable release of growth factors by the transfecting cells in 
the immediate implant area compared to the more traditional growth factor-carrying 
scaffolds (23). It is widely accepted that the stability and efficiency of viral 
transfection of cells is much higher than plasmid transfection. In this study, the use of 
a GFP labeled adenovirus allowed us to directly observe infected cells by 
fluorescence emission and to detect the relative efficiency of gene transfection in 
BMSCs. The method of design established in this study demonstrated that the 
adenovirus carrying BMP-7 was distributed evenly inside the silk scaffolds. When 
compared with other scaffold materials used to carry adenoviruses, silk maintains the 
bio-activity and transfectability of viruses much better as the solvents and processes 
used in the production of silk scaffold are tolerable to active viruses. Our results 
showed that the released viruses from the silk scaffold were capable of transfecting 
BMSCs in vitro until 14 days. The release profile was well controlled as the silk 
scaffold gradually degraded over a period of 21 days. There was a “delayed” 
adenovirus release from the scaffold, which reflected the results of the infection 
efficiency of BMSCs. The evidence of delayed release and high infection efficiency 
of virus could indicate that the adenovirus was encapsulated into the silk scaffold 
which served to protect the virus from unfavorable external environmental factors. 
The viral release profiles in this study showed a more controllable pattern compared 
with those of other scaffold materials reported in our previous published studies (6, 
7).    
 
We tested the in vivo ability of BMP-7 encoding adenovirus to transfect host cells in a 
critical sized bone defect model in SCID mice. The results from these experiments 
revealed that BMP-7 encoded by the virus enhanced the new bone formation 
compared to negative controls including the scaffolds containing the adenovirus 
alone. Interestingly, the addition of BMSCs onto the virus-carrying silk scaffold did 
not generate significant difference when compared with the Ad-BMP-7 scaffold alone. 
This observation indicates that the in vivo cell transfection efficiency of these 
Ad-BMP-7 were sufficiently high to impart osteogenesis-promoting roles to the cells 
in the immediate surroundings of the defect. The role of additional non-infected 
BMSCs in the osteogenic environment and their interaction with osteogenic 
differentiated BMSCs require further investigation. Histological and 
immunohistological staining confirmed the presence of new bone formation in the 
Ad-BMP-7 scaffolds, and also robust expression of COL1, ALP and OPN, which are 
all markers of new bone formation. ALP is widely used as a marker of the osteoblast 
phenotype and plays an important role in the maintenance of bone mineralization. 
High levels of ALP are seen in both pre-osteoblasts and osteoblasts in vivo and in 
vitro (24). Type I collagen is the most abundant protein in bone matrix, and is an early 
and mature marker of osteogenic differentiation. OPN is a major non-collagenous 
protein synthesized by differentiated osteoblasts and deposited into the mineralizing 
matrix (25). However, OPN does not play a role in the initial formation of mineral 
crystals in bone-like tissue as it does not bind to the collagenous matrix of bone. OPN 
can accumulate even if mineral formation is absent. The positive staining of these 
osteogenic markers indicates that the Ad-BMP-7 loaded silk scaffold can successfully 
induce the in vivo osteogenesis, bone matrix protein deposition and new bone 
formation. Given that incorporation of BMSCs into Ad-BMP-7 loaded silk scaffold 
does not significantly enhance in vivo osteogenesis and new bone formation, the 
method of using a virus-carrying silk scaffold alone to enhance the in vivo new bone 
formation and help large-sized bone defect healing holds much promise for future 
therapeutic applications. Even thought, there are a number of growth factor delivery 
devices available on the market, Ad-BMP-7 containing silk scaffold provides a cheap, 
biocompatible and effective approaches for bone defect repair and regeneration. The 
limitation of the current study is the biosafety of using adenovirus for clinical 
application, which requires further investigation.  
 
In summary, the silk scaffold carrying BMP-7 encoding adenoviruses can effectively 
transfect cells and enhance the osteogenesis both in vitro and in vivo. The findings of 
this study indicate that bio-active silk fibroin is a promising biomaterial for gene 
delivery scaffolds to repair critical-sized bone defects.  
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Legends 
 
Figure 1 SEM images of freeze-dried scaffolds. A&B. highly interconnected and 
porous structures of scaffold; C. Cells (arrow heads) on the scaffold one day after 
seeding; D. Cells (arrow heads) on the scaffold one week after seeding. 
 
 
Figure 2 The adenovirus releasing profile from the silk fibroin scaffolds over 
time  
 
 
Figure 3 In vitro infection efficiency of adenovirus released from scaffolds. A. 
Images show cell numbers and green fluorescence density of BMSCs successfully 
infected by the virus released at different time point (D2-D21: day 2 to 21). B. Bar 
graph showing the quantified infection efficiency of viruses released at different time 
point. C. Bar graph showing the BMP-7 concentration in the media collected at 
different time point from infected BMSCs.  
 
 
Figure 4 Bone defect healing by different scaffolds. A&B. 3D reconstructed Micro 
CT images of defect areas filled with no scaffolds (Group 1) or silk scaffold 
containing virus alone (Group 2); C&D. 3D reconstructed Micro CT images of defect 
areas filled with silk scaffold carrying Ad-BMP-7 (Group 3) (C) and silk scaffold 
carrying Ad-BMP-7 with BMSCs (Group 4) (D); E. Bar graph showing the amount of 
new bone volume within the defect from different groups. *: significant difference in 
comparison with group 1&2 (p<0.05). Bar=1 mm 
 
 
Figure 5 H&E staining on the defect samples. A. defect filled with no scaffolds; B. 
defects filled with silk scaffolds containing virus only; C&D. defects filled with silk 
scaffolds impregnated with Ad-BMP-7 with or without BMSCs; E&F. higher 
magnification showing the newly formed bone tissues inside the scaffold surrounded 
by osteoblasts (arrow heads: osteoblasts; NB: new bone tissues). Bar=100 m 
 
 
Figure 6 Immunohistochemical staining of defect samples. A&D Collagen I 
staining on the new bone tissues formed in the defect filled with Ad-BMP-7 loaded 
silk scaffold with (D) or without (A) BMSCs; B&E. ALP staining on the new bone 
tissues formed in the defect filled with Ad-BMP-7 loaded silk scaffold with (E) or 
without (B) BMSCs; C&F. OPN staining on the new bone tissues formed in the defect 
filled with Ad-BMP-7 loaded silk scaffold with (F) or without (C) BMSCs. Bar=200 
m 
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